| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.TP.0000203324.49969.30 |
| P698 | PubMed publication ID | 16641611 |
| P2093 | author name string | Sehsuvar Erturk | |
| Sule Sengul | |||
| Kenan Keven | |||
| Sim Kutlay | |||
| Bulent Erbay | |||
| Ulku Gormez | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1216-1219 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Identification of patients at risk of acute rejection by pretransplantation and posttransplantation monitoring of soluble CD30 levels in kidney transplantation | |
| P478 | volume | 81 |
| Q46246128 | Association between serum soluble CD30 and serum creatinine before and after renal transplantation. |
| Q46095776 | Association of high post-transplant soluble CD30 serum levels with chronic allograft nephropathy. |
| Q33842783 | Biomarkers in renal transplantation: An updated review |
| Q35942851 | High-dose immunosuppressant alters the immunological status of New Zealand white rabbits following skin transplantation |
| Q38733824 | Immunologic monitoring in kidney transplant recipients |
| Q33661464 | Increased Circulating T Lymphocytes Expressing HLA-DR in Kidney Transplant Recipients with Microcirculation Inflammation. |
| Q36512063 | Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies |
| Q37637948 | Noninvasive diagnosis of acute rejection of renal allografts |
| Q43272944 | Post-transplant increased levels of serum sCD30 is a marker for prediction of kidney allograft loss in a 5-year prospective study |
| Q85224322 | Post-transplant monitoring of soluble CD30 level as predictor of graft outcome: a single center experience from China |
| Q86779666 | Post-transplant soluble CD30 levels are associated with early subclinical rejection in kidney transplantation |
| Q43791140 | Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection |
| Q46163952 | Pre-transplant and post-transplant soluble CD30 for prediction and diagnosis of acute kidney allograft rejection |
| Q47335081 | Pretransplant soluble CD30 serum concentration does not affect kidney graft outcomes 3 years after transplantation |
| Q84521077 | Relative reductions in soluble CD30 levels post-transplant predict acute graft function in islet allograft recipients receiving three different immunosuppression protocols |
| Q86104164 | Soluble CD30 does not predict late acute rejection or safe tapering of immunosuppression in renal transplantation |
| Q91636280 | Soluble CD30, the Immune Response, and Acute Rejection in Human Kidney Transplantation: A Systematic Review and Meta-Analysis |
| Q43274504 | TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion. |
Search more.